Jumping genes can prevent blood cancers: Study
By IANS |
4 Views
Gallbladder, biliary tract cancer cases up 76% in 3 decades. Image Source: IANS News
New York, April 9 : US scientists have found that transposons, also known as jumping genes, can protect against certain blood cancers and help develop new therapeutic targets.
Transposons are DNA sequences that can move, or jump, from one location in the genome to another when activated. These jumping genes are a source of genetic mutations responsible for a number of human diseases.
The findings, published in the journal Nature Genetics, can help predict how patients will respond to cancer therapies and find new therapeutic targets for acute myeloid leukemia (AML) the deadliest type of blood cancer in adults and children.
Jumping genes can prevent blood cancers: Study - INDIA New England News
indianewengland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianewengland.com Daily Mail and Mail on Sunday newspapers.
Transposons can protect against certain blood cancers
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Zhimin Gu, Ph.D., postdoctoral fellow, Children s Medical Center Research Institute at UT Southwestern (CRI), and Jian Xu Ph.D., associate professor, CRI view more
Credit: UT Southwestern Medical Center
DALLAS - April 8, 2021 - New research has uncovered a surprising role for so-called jumping genes that are a source of genetic mutations responsible for a number of human diseases. In the new study from Children s Medical Center Research Institute at UT Southwestern (CRI), scientists made the unexpected discovery that these DNA sequences, also known as transposons, can protect against certain blood cancers.
These findings, published in
Nature Genetics, led scientists to identify a new biomarker that could help predict how patients will respond to cancer therapies and find new therapeutic targets for acute myeloid leukemia (AML), the deadliest type of blood cancer in adults and children.